Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for ...

The White House argues using tariffs as a constitutionally appropriate tool to advance his global goals. Spokesperson KUSH DESAI told NatSec Daily: “President Trump is committed to using every tool at ...